|
期刊名称：BMC PHARMACOLOGY & TOXICOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and scope
BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials.It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.
Open access
All articles published by BMC Pharmacology and Toxicology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in BMC Pharmacology and Toxicology you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Article-processing charges
Open access publishing is not without costs. BMC Pharmacology and Toxicology therefore levies an article-processing charge of £1370/$2145/€1745 for each article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
Indexing services
All articles published in BMC Pharmacology and Toxicology are included in:
- CABI
- CAS
- Citebase
- Embase
- Global Health
- Journal Citation Reports/Science Edition
- MEDLINE
- OAIster
- PubMed
- PubMed Central
- Science Citation Index Expanded
- SCImago
- Scopus
- SOCOLAR
- Zetoc
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
BMC Pharmacology and Toxicology has an Impact Factor of 1.840.
Publication and peer-review process
Publication of research articles by BMC Pharmacology and Toxicology is dependent primarily on their scientific validity and coherence as judged by our external expert editors and/or peer reviewers, who will also assess whether the writing is comprehensible and whether the work represents a useful contribution to the field.
Peer-review policy
Manuscripts submitted to BMC Pharmacology and Toxicology are assessed by our editors and/or peer reviewers. Section Editors provide oversight for manuscripts submitted to their section and overall editorial responsibility for the journal is with the Executive Editor. BMC Pharmacology and Toxicology operates using an open peer review system, where the reviewers' names are included on the peer review reports. In addition, if the article is published, the named reports are published online alongside the article as part of a 'pre-publication history' under a Creative Commons Attribution License 4.0. All previous versions of the manuscript, and all author responses to the reviewers are also available to readers.
BMC Pharmacology and Toxicology is part of the BMC series which publishes subject-specific journals focused on the needs of individual research communities across all areas of biology and medicine. We offer an efficient, fair and friendly peer review service, and are committed to publishing all sound science, provided that there is some advance in knowledge presented by the work.
BMC series - open, inclusive and trusted.
Editorial policies
All manuscripts submitted to BMC Pharmacology and Toxicology should adhere to BioMed Central's editorial policies.
Appeals and complaints
Authors who wish to appeal a rejection or make a complaint should, in the first instance, contact the Executive Editor who will provide details of the journal's complaints procedure.
Citing articles in BMC Pharmacology and Toxicology
Articles in BMC Pharmacology and Toxicology should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. BMC pharmacol toxicol [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. BMC pharmacol toxicol 2009, 1:115.
refers to article 115 from Volume 1 of the journal
Why publish your article in BMC Pharmacology and Toxicology
High visibility
BMC Pharmacology and Toxicology 's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
BMC Pharmacology and Toxicology offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Flexibility
Online publication in BMC Pharmacology and Toxicology gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in BMC Pharmacology and Toxicology are included in article alerts and regular email updates. Some may be highlighted on BMC Pharmacology and Toxicology ’s pages and on the BioMed Central homepage.
In addition, articles published in BMC Pharmacology and Toxicology may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in BMC Pharmacology and Toxicology . A list of articles recently press-released by journals published by BioMed Central is available here.
Copyright
As an author of an article published in BMC Pharmacology and Toxicology you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.
Instructions to Authors
Submission Guidelines
Before you submit your manuscript, please ensure that you have satisfied all formatting requirements and have all the required supporting information as listed below. If you have any questions about the submission process or preparation of your manuscript, please contact info@biomedcentral.com.
Manuscripts cannot be submitted to more than one journal at a time and cannot be submitted by anyone other than one of the authors. The submitting author takes responsibility for the submission on behalf of all authors. All authors must consent to the submission.
1. Correctly format your manuscript
BMC Pharmacology and Toxicology publishes the following article types. Please click on the relevant article type below for instructions on how to format your manuscript.
Figures
Figures must be uploaded as separate files and not embedded in your manuscript.
See Preparing figures for more information.
Tables
Smaller tables that are considered integral to the manuscript can be pasted at the end of the manuscript file in A4 portrait or landscape format. Larger tables can be uploaded separately as additional files.
See Preparing tables for more information.
Additional files
You may provide datasets, tables, movies, or other information as additional files. These will be published along with the article. Do not include files such as patient consent forms, certificates of language editing, or revised versions of the main manuscript document with tracked changes.
The maximum file size for additional files is 20MB each, and files will be virus-scanned on submission.
See Preparing additional files for more information.
2. Prepare supporting information
Please make sure you have the following information available before you attempt to submit your manuscript:
Author information
Full names and email addresses of all co-authors on your manuscript.
Cover letter
A cover letter that includes the following information, as well as any additional information requested in the instructions for your specific article type (see main manuscript section above):
- An explanation of why your manuscript should be published in BMC Pharmacology and Toxicology
- An explanation of any issues relating to journal policies
- A declaration of any potential competing interests
- Confirmation that all authors have approved the manuscript for submission
- Confirmation that the content of the manuscript has not been published, or submitted for publication elsewhere (see our duplicate publication policy)
- If you are submitting a manuscript to a particular special issue, please refer to its specific name in your covering letter
You may suggest potential peer reviewers for your manuscript. If you wish to do so, please provide institutional email addresses where possible, or information which will help the Editor to verify the identity of the reviewer (for example an ORCID or Scopus ID). Intentionally falsifying information, for example, suggesting reviewers with a false name or email address, will result in rejection of your manuscript and may lead to further investigation in line with our misconduct policy. See our editorial policies for guidance on suggesting peer reviewers.
Excluding peer reviewers
During submission you may enter details of anyone who you would prefer not to review your manuscript.
The following information must be included under the Declarations section of your manuscript. You will be asked about this information during submission of your manuscript.
Declarations
Ethics approval and consent to participate
Manuscripts reporting studies involving human participants, human data or human tissue must include a statement on ethics approval and consent. Studies involving animals must include a statement on ethics approval.
See our editorial policies for more information.
Consent to publish
All manuscripts containing any individual person’s data in any form require consent to publish from that person, or in the case of children, their parent or legal guardian.
See our editorial policies for more information.
Availability of data and materials
For all journals, you must include an 'Availability of data and materials' section within the ‘Declarations’ of your manuscript detailing where the data supporting your findings can be found. For some journals, deposition of your data is mandatory (see information on individual article types above). For journals where data deposition is not mandatory, BioMed Central strongly encourages all datasets on which the conclusions of the manuscript rely be either deposited in publicly available repositories or presented in the main paper or additional supporting files. If you do not wish to share your data, please state that data will not be shared, and state the reason.
See our editorial policies and preparing your manuscript for more information.
Competing interests
All financial and non-financial competing interests must be declared in this section. You will be asked about this during submission of your manuscript.
See our editorial policies for more information on competing interests.
Funding
All sources of funding for the research reported should be declared.
3. Agree to conditions of submission, BioMed Central’s copyright and license agreement and article-processing charge (APC)
Copyright and license agreement
During submission, you will need to accept and confirm the following conditions of submission:
- All authors of the manuscript have read and agreed to its content and are accountable for all aspects of the accuracy and integrity of the manuscript in accordance with ICMJE criteria
- That the manuscript is original, has not already been published in a journal, and is not currently under consideration by another journal
- That you agree to the terms of the BioMed Central Copyright and License Agreement and Open data policy, which we strongly recommend you read. For authors who are prevented from being copyright holders (for instance where Crown Copyright applies or researchers are US government employees) BioMed Central can accommodate nonstandard copyright lines. If this applies to you, please contact us and provide details of your situation
- For more information see our Copyright and license policy
Article-processing charge
An article-processing charge (APC) applies for each article accepted for publication in BMC Pharmacology and Toxicology . For details of the journal's APC see About BMC Pharmacology and Toxicology and for answers to some frequently-asked questions please see our article-processing charge page.
Editorial Board
Section Editors
Michael Aschner, Albert Einstein College of Medicine, USA
Phil Biggin, University of Oxford, UK
David H Farb, Boston University School of Medicine, USA
Lucio Guido Costa, University of Washington, USA
Giorgio Palu, University of Padova, Italy
Catherine Sherwin, University of Utah School of Medicine, USA
Associate Editors
Basic pharmacology
Salvatore Amoroso, Università Politecnica delle Marche, Italy
István Baczkó, University of Szeged, Hungary
Francesco Clementi, University of Milan, Italy
Nissar Darmani, Western University of Health Sciences, USA
Fabrizio De Ponti, University of Bologna, Italy
Steven Holladay, Virginia Tech, USA
David Jane, University of Bristol, UK
Trisha A Jenkins, RMIT University, Australia
François Marceau, Centre Hospitalier Hospitalier Universitaire de Québec, Canada
Maurizio Memo, University of Brescia Medical School, Italy
Noel G Morgan, Peninsula Medical School, UK
Carlo Riccardi, University of Perugia, Italy
Fernando Rodrigues, Lima University Paris Diderot, France
Shelley J Russek, Boston University, USA
Graeme J Sills, University of Liverpool, UK
Cara Williams, Pfizer, USA
Clinical pharmacology
Hesham Al-Sallami, University of Otago, New Zealand
Alfred Balch, University of Utah School of Medicine, USA
Douglas Ball, Independent Pharmaceutical Consultancy, Philippines
Jos H Beijnen, Netherlands Cancer Institute, Netherlands
Stephen Bleakley, NHS, UK
Sarah Campbell, Nelson Laboratories, USA
Domenico Capone, Federico II University, Italy
Philip Debruyne, AZ Groeninge, Belgium
Didier Decaudin, Curie Institute, France
Brian Decker, Indiana University School of Medicine, USA
Elena Y Enioutina, University of Utah, USA
Melanie Felmlee, University of the Pacific, USA
QiPing Feng, Vanderbilt University, USA
Simone Ferrero, Università degli Studi di Torino, Italy
Marina Galvez Peralta, School of Pharmacy, USA
Shazia Jamshed, International Islamic University Malaysia (IIUM), Malaysia
Reem Kayyali, Kingstong University, UK
Enoch Kwizera, University of Transkei, South Africa
Chun Shing Kwok, Ipswich Hospital, UK
Charles E. Leonard, Perelman School of Medicine at the University of Pennsylvania, USA
Joanne Lymn, University of Nottingham, UK
Anke Hilse, Maitland-van der Zee Utrecht University, Netherlands
Kathryn Momary, Mercer University, USA
Gene D Morse, University at Buffalo, USA
Stefania Nobili, University of Florence, Italy
Roberto Passera, University of Torino, Italy
Vidya Perera, Bristol Myers Squibb, USA
Balmiki Ray, Assurex Health, USA
Gavin Reynolds, Sheffield Hallam University, UK
Nam Tran, University of California, Davis, USA
Tian Yu, The University of Utah, USA
Computational, in silico and modeling studies
Serdar Durdagi, Bahcesehir University, Turkey
Maria Miteva, University Paris Diderot, France
Xavier Morelli, Cancer Research Center of Marseille (CRCM), France
Sergei Noskov, University of Calgary, Canada
Xiang-Qun Xie, University of Pittsburgh, USA
Drug design, discovery and delivery
Margherita Brindisi, University of Siena, Italy
Simone Brogi, University of Siena, Italy
Richard Bryce, University of Manchester, UK
Gautam Damera, Medimmune, USA
Corey Hopkins, Vanderbilt University, USA
Bhaskar Jasti, University of Pacific, USA
Afzal R Mohammed, Aston University, Birmingham, UK
Preet Mohinder Singh Bedi, Guru Nanak Dev University, India
Sahil Sharma, Guru Nanak Dev University, India
Toxicology
Aaron B Bowman, Vanderbilt University, USA
Brent A Carter, University of Iowa Carver College of Medicine, USA
Emanuela Corsini, University of Milan, Italy
Julia Yue Cui, University of Washington, USA
Robert Gogal, University of Georgia, USA
Tai Guo, University of Georgia, USA
Joel Meyer, Duke University, USA
Claudia Pellacani, University of Parma, Italy
Angela Slitt, University of Rhode Island, USA
Editorial Advisors
Christian Bailly, Pierre Fabre Research Institute, France
Norman G Bowery, University of Birmingham, UK
Johannes Bufler, Inn-Salzach-Klinikum, Germany
Bernard M Cheung, Queen Mary Hospital, Hong Kong
Kanwaljit Chopra, Panjab University, India
Martin Duerden, Conwy Local Health Board, UK
Roderic G Eckenhoff, University of Pennsylvania School of Medicine, USA
Robin C Hiley, University of Cambridge, UK
Paul Insel, University of California, USA
Terry Kenakin, University of North Carolina School of Medicine, USA
Winfried V Kern, University Hospital of Freiburg, Germany
Rajesh Krishna, Merck Research Laboratories, USA
Hans Lennernas, Uppsala University, Sweden
Donald Maurice, Queen's University, Canada
Jacopo Meldolesi, Vita-Salute San Raffaele University, Italy
Jennifer A Morton, University of Cambridge, UK
Piero Olliaro, World Health Organization, Switzerland
Clive Page, Kings College London, UK
Michael A. Rogawski, National Institute of Neurological Disorders and Stroke, USA
Edith Sim, University of Oxford, UK
Trevor G Smart, University College London, UK
Alex Sparreboom, National Cancer Institute, USA
Brian L Strom, University of Pennsylvania School of Medicine, USA
Cornelis J Van der Schyf, Northeast Ohio Medical University, USA
George F Vande, Woude Van Andel Research Institute, USA
John T Wilson, Louisiana State University Health Sciences Center, USA
Uri Wormser, The Hebrew University, Israel
|
|
|
|
